Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Donald A Mahler, Henrik Watz, Rachel Emerson-Stadler, John Ritz, Asparuh Gardev, Asif Shaikh & M Bradley Drummond. (2023) Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1729-1740.
Read now
Read now
Varsha Komalla, Chun Yuen Jerry Wong, Imco Sibum, Bernhard Muellinger, Wietze Nijdam, Vishal Chaugule, Julio Soria, Hui Xin Ong, Nicolas A. Buchmann & D. Traini. (2023) Advances in soft mist inhalers. Expert Opinion on Drug Delivery 20:8, pages 1055-1070.
Read now
Read now
Nur Azimah Mohd Rhazi, Jaya Muneswarao, Fatimatuzzahra’ Abdul Aziz, Baharudin Ibrahim, Azlan Kamalludin & Shahrul Aiman Soelar. (2023) Can patients achieve sufficient peak inspiratory flow rate (PIFR) with Turbuhaler® during acute exacerbation of asthma?. Journal of Asthma 60:8, pages 1608-1612.
Read now
Read now
Marco Contoli, Sara Barile, Elena Nudo, Daniele Guastalla & Fulvio Braido. (2022) Exploring quality of life and satisfaction with treatment in asthmatic patients receiving dry powder inhalers: a multinational survey. Journal of Asthma 59:7, pages 1473-1483.
Read now
Read now
Arschang Valipour, Zaurbek Aisanov, Sergey Avdeev, Vladimir Koblizek, Ivan Kocan, Ivan Kopitovic, Gergely Lupkovics, Milena Man, Maris Bukovskis, Neven Tudoric, Marija Vukoja, Wojciech Naumnik & Nikolay Yanev. (2022) Recommendations for COPD management in Central and Eastern Europe. Expert Review of Respiratory Medicine 16:2, pages 221-234.
Read now
Read now
Donald A Mahler, Andrea Ludwig-Sengpiel, Gary T Ferguson, Alberto de la Hoz, John Ritz, Asif Shaikh & Henrik Watz. (2021) TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2455-2465.
Read now
Read now
Adolfo Baloira, Araceli Abad, Antonia Fuster, Juan Luis García Rivero, Patricia García-Sidro, Eduardo Márquez-Martín, Marta Palop, Néstor Soler, J L Velasco & Fernando González-Torralba. (2021) Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1021-1033.
Read now
Read now
Mariam Fathima, Zeeta Bawa, Bernadette Mitchell, Juliet Foster, Carol Armour & Bandana Saini. (2021) COPD Management in Community Pharmacy Results in Improved Inhaler Use, Immunization Rate, COPD Action Plan Ownership, COPD Knowledge, and Reductions in Exacerbation Rates. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 519-533.
Read now
Read now
Omar S Usmani, Nicolas Roche, Martin Jenkins, Neda Stjepanovic, Peter Mack & Wilfried De Backer. (2021) Consistent Pulmonary Drug Delivery with Whole Lung Deposition Using the Aerosphere Inhaler: A Review of the Evidence. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 113-124.
Read now
Read now
Anne Tschacher, Cordula Cadus, Sebastian Schildge, Jens Peter Diedrich, Prashant N. Chhajed, Anne B. Leuppi-Taegtmeyer & Jörg Daniel Leuppi. (2021) Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland. Current Medical Research and Opinion 37:11, pages 2019-2033.
Read now
Read now
Andriana I. Papaioannou, Konstantinos Bartziokas, Georgios Hillas, Evangelia Fouka, Katerina Dimakou, Maria Kallieri, Stamatoula Tsikrika, Georgia Papadaki, Evgenia Papathanasiou, Anastasia Papaporfyriou, Vasiliki Apollonatou, Galateia Verykokou, Myrto Mplizou, Despina Papakosta, Effrosyni D. Manali, Spyridon Papiris & Stelios Loukides. (2021) Device use errors among patients with asthma and COPD and the role of training: a real-life study. Postgraduate Medicine 133:5, pages 524-529.
Read now
Read now
Antonio L. Valero, José A. Trigueros & Vicente Plaza. (2021) Multidisciplinary consensus on inhaled therapy in asthma. Expert Review of Respiratory Medicine 15:3, pages 425-434.
Read now
Read now
Katharina Ruessel, Eva Luecke & Jens Schreiber. (2020) Inhaler Devices in a Geriatric Patient Population: A Prospective Cross-Sectional Study on Patient Preferences. Patient Preference and Adherence 14, pages 1811-1822.
Read now
Read now
Timothy E. Albertson, Janelle V. Pugashetti, Florence Chau-Etchepare, James A. Chenoweth & Susan Murin. (2020) Pharmacotherapeutic management of asthma in the elderly patient. Expert Opinion on Pharmacotherapy 21:16, pages 1991-2010.
Read now
Read now
Mario Cazzola, Francesco Cavalli, Omar S. Usmani & Paola Rogliani. (2020) Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Delivery 17:5, pages 635-646.
Read now
Read now
David Singer, Lindsay G S Bengtson, Caitlin Elliott, Ami R Buikema & Jessica Franchino-Elder. (2020) Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3239-3250.
Read now
Read now
John R Hurst, Kevin Gruffydd-Jones, Mousumi Biswas, Deniz Guranlioglu, Martin Jenkins, Neda Stjepanovic & Arushi Bamrara. (2020) Efficacy and Safety of LAMA/LABA Fixed-Dose Combination Therapies in Chronic Obstructive Pulmonary Disease: A Systematic Review of Direct and Indirect Treatment Comparisons. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1529-1543.
Read now
Read now
David J Collier, Pascal Wielders, Job van der Palen, Logan Heyes, Dawn Midwinter, Kathryn Collison, Andy Preece, Neil Barnes & Raj Sharma. (2020) Critical Error Frequency and the Impact of Training with Inhalers Commonly used for Maintenance Treatment in Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1301-1313.
Read now
Read now
Maria Gabriella Matera, Carmela Belardo, Michele Rinaldi, Barbara Rinaldi & Mario Cazzola. (2020) Emerging muscarinic receptor antagonists for the treatment of asthma. Expert Opinion on Emerging Drugs 25:2, pages 123-130.
Read now
Read now
Articles from other publishers (50)
Jacob Cohen, Iris Rosenbaum, Bernice Oberman, Irit Katz, Naama Sharabi & Dekel Shlomi. (2023) The impact of pharmacist-guided inhaler technique education on chronic obstructive pulmonary disease and asthma patients. Journal of Pharmaceutical Health Services Research 14:2, pages 198-204.
Crossref
Crossref
Christer Janson, Jaime Hernando Platz, Stéphane Soulard, Sue Langham, Lindsay Nicholson & Elisabeth Sophia Hartgers-Gubbels. (2023) Reducing carbon footprint by switching to reusable soft-mist inhalers. ERJ Open Research 9:3, pages 00543-2022.
Crossref
Crossref
Anna Murphy, David Howlett, Aaron Gowson & Harriet Lewis. (2023) Understanding the feasibility and environmental effectiveness of a pilot postal inhaler recovery and recycling scheme. npj Primary Care Respiratory Medicine 33:1.
Crossref
Crossref
Michael Y.T. Chow, Harry W. Pan & Jenny K.W. Lam. 2023. Pulmonary Pharmacology. Pulmonary Pharmacology
273
311
.
Hezhi Wang, Lu Qin, Xin Zhang, Jian Guan & Shirui Mao. (2022) Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery. Journal of Controlled Release 352, pages 970-993.
Crossref
Crossref
Monbi Chakma & Omar Usmani. (2022) Inhalers and the Environment: Pollution, Plastics and Policy. Pneumon 35:4, pages 1-9.
Crossref
Crossref
Marilyn Urrutia-Pereira1, Herberto José Chong-Neto2, Tonya A Winders3 & Dirceu Solé4. (2022) Environmental impact of inhaler devices on respiratory care: a narrative review. Jornal Brasileiro de Pneumologia, pages e20220270.
Crossref
Crossref
Zhaoqi Ma, Agisilaos Kourmatzis, Liam Milton-McGurk, Hak-Kim Chan, Dino Farina & Shaokoon Cheng. (2022) Simulating the effect of individual upper airway anatomical features on drug deposition. International Journal of Pharmaceutics 628, pages 122219.
Crossref
Crossref
Tuula Vasankari, Federico Lavorini, Christer Janson, Lauri Lehtimäki, Eric Bateman, Dave Singh, Charlotte Suppli Ulrik, Ashley Woodcock & Alvar Agusti. (2022) Contemporary Challenges in the Management of Asthma and Chronic Obstructive Pulmonary Disease: Expert Perspectives on Optimising Outcomes Through Guidelines Implementation, Inhaler Selection, and Patient Engagement. EMJ Respiratory, pages 31-42.
Crossref
Crossref
Ruth Tal-Singer, Linda Walsh, Tim Deuby, Angela Shaughnessy, Karin F Hoth, Victor Gascon, Susanne Hintringer, Nicole Hass, Tonya Winders, Lucy Morgan, Byron Thomashow & David M Mannino. (2022) Tobacco industry ownership of pharmaceutical companies: an international survey of people with respiratory disease. Thorax 77:10, pages 1045-1047.
Crossref
Crossref
N. Roche, B. Aggarwal, I. Boucot, L. Mittal, A. Martin & H. Chrystyn. (2022) The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: A systematic review. Respiratory Medicine 202, pages 106949.
Crossref
Crossref
Biljana Cvetkovski, Charlotte Hespe, Rachel House, Vicky Kritikos, Elizabeth Azzi, Jack Evans, Pamela Srour-Alphonse & Sinthia Bosnic-Anticevich. (2022) Exploring General Practitioners’ Preferences and Experience with Respiratory Inhaler Devices. Pulmonary Therapy 8:3, pages 283-296.
Crossref
Crossref
David M. G. Halpin & Donald A. Mahler. (2022) A Systematic Review of Published Algorithms for Selecting an Inhaled Delivery System in Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society 19:7, pages 1213-1220.
Crossref
Crossref
Ashley Woodcock, Kai M. Beeh, Hironori Sagara, Simon Aumônier, Emmanuel Addo-Yobo, Javaid Khan, Jørgen Vestbo & Helen Tope. (2022) The environmental impact of inhaled therapy: making informed treatment choices. European Respiratory Journal 60:1, pages 2102106.
Crossref
Crossref
Mona Al-Ahmad & David Webb. (2022) A prospective study of switching asthma patients from a Fixed-Dose Combination (FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised Metered Dose Inhaler (pMDI). Respiratory Medicine 194, pages 106771.
Crossref
Crossref
William W. Busse & Monica Kraft. (2022) Current unmet needs and potential solutions to uncontrolled asthma. European Respiratory Review 31:163, pages 210176.
Crossref
Crossref
Jesús Molina París. (2022) [Translated article] Inhalation Devices and Climatic Change. Archivos de Bronconeumología 58:3, pages T287.
Crossref
Crossref
Jesús Molina París. (2022) Dispositivos de inhalación y cambio climático. Archivos de Bronconeumología 58:3, pages 287.
Crossref
Crossref
Didier Cataldo, Shane Hanon, Rudi V. Peché, Daniel J. Schuermans, Jean M. Degryse, Isabelle A. De Wulf, Karin Elinck, Mathias H. Leys, Peter L. Rummens & Eric Derom. (2022) How to Choose the Right Inhaler Using a Patient-Centric Approach?. Advances in Therapy 39:3, pages 1149-1163.
Crossref
Crossref
Marek Lommatzsch. (2022) Diagnostik und Therapie von Asthma bei ErwachsenenThe diagnosis and treatment of asthma in adults. Der Pneumologe 19:2, pages 111-121.
Crossref
Crossref
Daljeet Singh Dhanjal, Parvarish Sharma, Meenu Mehta, Murtaza M Tambuwala, Parteek Prasher, Keshav R Paudel, Gang Liu, Shakti D Shukla, Philip M Hansbro, Dinesh Kumar Chellappan, Kamal Dua & Saurabh Satija. (2022) Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases. Future Medicinal Chemistry 14:4, pages 271-288.
Crossref
Crossref
Natalie Anderson, Sarah Clarke & Britta S. von Ungern‐Sternberg. (2021) Aerosolized drug delivery in awake and anesthetized children to treat bronchospasm. Pediatric Anesthesia 32:2, pages 156-166.
Crossref
Crossref
Selvaraj Nitya, Sivagourounadin Kiruthika, R Meenakshi, H Suriya & S Yuvarajan. (2022) A cross-sectional study of pre- and posttraining evaluation of inhaler use technique among outpatients with bronchial asthma or chronic obstructive pulmonary disease at a tertiary care hospital in India. Perspectives in Clinical Research 13:4, pages 184.
Crossref
Crossref
Sandra Anderson, Paul Atkins, Per Bäckman, David Cipolla, Andrew Clark, Evangelia Daviskas, Bernd Disse, Plamena Entcheva-Dimitrov, Rick Fuller, Igor Gonda, Hans Lundbäck, Bo Olsson & Jeffry Weers. (2022) Inhaled Medicines: Past, Present, and Future. Pharmacological Reviews 74:1, pages 48-118.
Crossref
Crossref
Josh Williams, Jari Kolehmainen, Steve Cunningham, Ali Ozel & Uwe Wolfram. (2022) Effect of patient inhalation profile and airway structure on drug deposition in image-based models with particle-particle interactions. International Journal of Pharmaceutics 612, pages 121321.
Crossref
Crossref
Omar S Usmani. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
754
765
.
Elena Haettig & Marc Schneider. 2022. Essentials of Industrial Pharmacy. Essentials of Industrial Pharmacy
123
149
.
Konstantinos Kostikas. (2021) Real-life effectiveness of ICS/LABA inhalers in
asthma: The evidence generated and future needs for
optimal patient management. Pneumon, pages 1-3.
Crossref
Crossref
Daniele Pernigotti, Carol Stonham, Sara Panigone, Federica Sandri, Rossella Ferri, Yasemin Unal & Nicolas Roche. (2021) Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries. BMJ Open Respiratory Research 8:1, pages e001071.
Crossref
Crossref
Meshari F Alwashmi, Gerald Mugford, Brett Vokey, Waseem Abu-Ashour & John Hawboldt. (2021) Effectiveness of the BreatheSuite Device in Assessing the Technique of Metered-Dose Inhalers: Validation Study. JMIR Biomedical Engineering 6:4, pages e26556.
Crossref
Crossref
Omar S. Usmani, Anthony J. Hickey, Deniz Guranlioglu, Kacey Rawson, Neda Stjepanovic, Shahid Siddiqui & Rajiv Dhand. (2021) The Impact of Inhaler Device Regimen in Patients with Asthma or COPD. The Journal of Allergy and Clinical Immunology: In Practice 9:8, pages 3033-3040.e1.
Crossref
Crossref
Jatica Ratanadadas, Thananan Rattanachotphanit & Chulaporn Limwattananon. (2020) Self-administration of medications for chronic diseases and drug-related hospital admissions in elderly patients at a Thai hospital. International Journal of Clinical Pharmacy 43:4, pages 864-871.
Crossref
Crossref
Shih-Yu Chen, Chun-Kai Huang, Hui-Chuan Peng, Hsing-Chen Tsai, Szu-Ying Huang, Chong-Jen Yu & Jung-Yien Chien. (2021) Peak-Inspiratory-Flow-Rate Guided Inhalation Therapy Reduce Severe Exacerbation of COPD. Frontiers in Pharmacology 12.
Crossref
Crossref
H. Edward DavidsonPeter RadlowskiLisa HanTheresa I. ShiremanCarole DembekXiaoli NiuStefan Gravenstein. (2021) Clinical Characterization of Nursing Facility Residents With Chronic Obstructive Pulmonary Disease. The Senior Care Pharmacist 36:5, pages 248-257.
Crossref
Crossref
Basima A. Almomani, Batool S. Al‐Qawasmeh, Samah F. Al‐Shatnawi, Samah Awad & Sirin A. Alzoubi. (2021) Predictors of proper inhaler technique and asthma control in pediatric patients with asthma. Pediatric Pulmonology 56:5, pages 866-874.
Crossref
Crossref
Yingmin Liang & Judith C.W. Mak. (2021) Inhaled Therapies for Asthma and Chronic Obstructive Pulmonary Disease. Current Pharmaceutical Design 27:12, pages 1469-1481.
Crossref
Crossref
Sarah E. Petite, Michael W. Hess & Herbert Wachtel. (2020) The Role of the Pharmacist in Inhaler Selection and Education in Chronic Obstructive Pulmonary Disease. Journal of Pharmacy Technology 37:2, pages 95-106.
Crossref
Crossref
Ling Ding, Siyuan Tang, Todd A. Wyatt, Daren L. Knoell & David Oupický. (2021) Pulmonary siRNA delivery for lung disease: Review of recent progress and challenges. Journal of Controlled Release 330, pages 977-991.
Crossref
Crossref
John Haughney, Amanda J. Lee, Eddie McKnight, Inna Pertsovskaya, Michelle O'Driscoll & Omar S. Usmani. (2021) Peak Inspiratory Flow Measured at Different Inhaler Resistances in Patients with Asthma. The Journal of Allergy and Clinical Immunology: In Practice 9:2, pages 890-896.
Crossref
Crossref
Yaseen Hussain, Jing-Hao Cui, Haroon Khan, Pooyan Makvandi & Waqas Alam. (2021) Biomacromolecule-mediated pulmonary delivery of siRNA and anti-sense oligos: challenges and possible solutions. Expert Reviews in Molecular Medicine 23.
Crossref
Crossref
Nicola Ullmann, Antonio Di Marco, Fabiana Columbu, Valentina Negro, Maria Beatrice Chiarini Testa, Valentina Panetta, Salvatore Tripodi, Ekaterina Potapova, Annalisa Allegorico, Paolo Maria Matricardi & Renato Cutrera. (2020) A Novel, Portable MESH Nebulizer—An Alternative to Metered Dose Inhaler: Efficacy and Usability in Preschool Wheezers. Frontiers in Pediatrics 8.
Crossref
Crossref
Jens Schreiber, Tina Sonnenburg & Eva Luecke. (2020) Inhaler devices in asthma and COPD patients – a prospective cross-sectional study on inhaler preferences and error rates. BMC Pulmonary Medicine 20:1.
Crossref
Crossref
Wanqing Wang, Tao Xu, Qiong Qin, Liyan Miao, Jian’an Bao & Rong Chen. (2020) Effect of a Multidimensional Pharmaceutical Care Intervention on Inhalation Technique in Patients with Asthma and COPD. Canadian Respiratory Journal 2020, pages 1-10.
Crossref
Crossref
Tamas ErdelyiZsofia LazarBalazs OdlerLilla TamasiVeronika Müller. (2020) The Repeatability of Inspiration Performance Through Different Inhalers in Patients with Chronic Obstructive Pulmonary Disease and Control Volunteers. Journal of Aerosol Medicine and Pulmonary Drug Delivery 33:5, pages 271-281.
Crossref
Crossref
Marek Lommatzsch, Roland Buhl & Stephanie Korn. (2020) The Treatment of Mild and Moderate Asthma in Adults. Deutsches Ärzteblatt international.
Crossref
Crossref
Marsha Tan, Felisa Reyes-Ortega & Elena K. Schneider-Futschik. (2020) Successes and Challenges: Inhaled Treatment Approaches Using Magnetic Nanoparticles in Cystic Fibrosis. Magnetochemistry 6:2, pages 25.
Crossref
Crossref
Paula J. Busse, Vanessa M. McDonald, Juan P. Wisnivesky & Peter G. Gibson. (2020) Asthma Across the Ages: Adults. The Journal of Allergy and Clinical Immunology: In Practice 8:6, pages 1828-1838.
Crossref
Crossref
Duncan Keeley, Jane E. Scullion & Omar S. Usmani. (2020) Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers. European Respiratory Journal 55:2, pages 2000048.
Crossref
Crossref
Rafael Bautista-Méndez, Erika Salinas-Lezama, Liliana de Jesús Bonola-Gallardo, Rey David Pineda-Gudiño & Gerardo Ezequiel Magdaleno-Maldonado. (2020) Selección en la diversidad de inhaladores: una actualización de bolsillo. NCT Neumología y Cirugía de Tórax 79:3, pages 204-207.
Crossref
Crossref
Laura Wiffen, Jessica Gates, Thomas Brown, Hitasha Rupani, Jayne Longstaff & AJ Chauhan. (2019) Chronic asthma in adults. InnovAiT: Education and inspiration for general practice 13:1, pages 29-38.
Crossref
Crossref